EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | 2Br.C22H32N4O4 |
| Net Charge | 0 |
| Average Mass | 576.330 |
| Monoisotopic Mass | 574.07903 |
| SMILES | CN(CCCCCCN(C)C(=O)Oc1ccc[n+](C)c1)C(=O)Oc1ccc[n+](C)c1.[Br-].[Br-] |
| InChI | InChI=1S/C22H32N4O4.2BrH/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20;;/h9-14,17-18H,5-8,15-16H2,1-4H3;2*1H/q+2;;/p-2 |
| InChIKey | GJHSNEVFXQVOHR-UHFFFAOYSA-L |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | EC 3.1.1.8 (cholinesterase) inhibitor An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| distigmine bromide (CHEBI:31512) has part distigmine (CHEBI:80756) |
| distigmine bromide (CHEBI:31512) has role EC 3.1.1.8 (cholinesterase) inhibitor (CHEBI:37733) |
| distigmine bromide (CHEBI:31512) is a organic bromide salt (CHEBI:48369) |
| distigmine bromide (CHEBI:31512) is a pyridinium salt (CHEBI:38188) |
| IUPAC Name |
|---|
| 3,3'-{hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridinium) dibromide |
| INNs | Source |
|---|---|
| distigmine bromide | WHO MedNet |
| bromure de distigmine | WHO MedNet |
| distigmini bromidum | WHO MedNet |
| bromuro de distigmina | WHO MedNet |
| Synonyms | Source |
|---|---|
| 3,3'-{hexane-1,6-diylbis[(methylcarbamoyl)oxy]}bis(1-methylpyridin-1-ium) dibromide | IUPAC |
| hexamarium bromide | ChEBI |
| BC 51 | ChemIDplus |
| 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium) dibromide | ChemIDplus |
| BC-51 | ChEBI |
| Brand Names | Source |
|---|---|
| Ubretid | KEGG DRUG |
| Adcostigmine | ChEBI |
| Ubritil | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| D01228 | KEGG DRUG |
| Distigmine | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:15876-67-2 | ChemIDplus |
| Citations |
|---|